About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDNA

Clinical Evaluation of the miraDry System in Subjects With Hyperhidrosis

NCT01091129•Miramar Labs

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Axillary Hyperhidrosis

Interventions

miraDry System (treatment with energy)

Locations

2

Canada

Locations (2)

Guildford Dermatology Specialists

Surrey, British Columbia, Canada

Cosmedica

Victoria, British Columbia, Canada

Key Dates

Start Date

February 1, 2010

Primary Completion Date

January 1, 2011

Completion Date

January 1, 2012

Last Updated

December 9, 2014

Related Studies

WITHDRAWNPhase 2

Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis

NCT04159610

Primary Axillary Hyperhidrosis

COMPLETEDPhase 3

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)

NCT03836287

Axillary Hyperhidrosis

COMPLETEDPhase 3

Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.

NCT03658616

Primary Axillary Hyperhidrosis

COMPLETEDPhase 2

A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis

NCT03785587

Primary Axillary Hyperhidrosis

Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis

NCT03320096

Axillary Hyperhidrosis

Ulthera® System for Treating Axillary Hyperhidrosis

NCT02286765

Primary Axillary Hyperhidrosis

View all related studies

Sponsors

Lead Sponsor

Miramar Labs

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions